About the Advanced Pediatric Thyroid Cancer Therapeutics Clinic
The Advanced Pediatric Thyroid Cancer Therapeutics Clinic at Children’s Hospital of Philadelphia (CHOP) is run by leading experts in Endocrinology and Oncology. In partnership with CHOP’s Developmental Therapeutics Program, our multidisciplinary team evaluates and treats pediatric thyroid cancer patients with progressive, refractory (treatment-resistant) disease, who may benefit from newly available targeted and systemic therapies.
Our experts each offer unique expertise that contributes to the management of patients with advanced thyroid cancer in this multi-disciplinary clinic. Andrew Bauer, MD, is an internationally recognized expert in the evaluation and treatment of thyroid cancer in children, and serves as Co-chair of the American Thyroid Association Pediatric Thyroid Cancer Guidelines Taskforce for the evaluation and management of differentiated thyroid cancer in children. Marcia Brose, MD, PhD, and Theodore Laetsch, MD, have each led and currently serve on multi-center trials of targeted therapies for cancer patients with advanced disease, including those whose tumors have mutations in the BRAF, NTRK and RET genes, which are common in pediatric thyroid cancer.
Because thyroid cancer can be a persistent disease spanning from pediatrics into adulthood, our patients also benefit from our ongoing partnership with the Hospital of the University of Pennsylvania (HUP). Dr. Brose is an adult oncologist at HUP who specializes in advanced thyroid cancer and serves as an expert consultant, ensuring patients have a seamless transition from pediatric to adult care.